For security reasons, you will be logged out in 4 minutesCannot be added!Your basket contains a blocked quote and must be finalised before you can order other items.Add to basket...Item added to basket
Error when adding ref. {0} to favouritesError when removing ref. {0} from favourites
Print or save as PDF
You will be redirected to your browser's interface for printing and saving as a PDF. Choose the option that's best for you from the "Destination" drop-down menu.
There are four types of Influenza (flu) viruses: type A, B, C, and D. Influenza A and B viruses are routinely spread in people and other mammals, while also known for seasonal flu epidemics each year. Influenza A is the genus Alphainfluenzavirus of the virus family Orthomyxoviridae. Influenza A is classified into two main protein subtypes, hemagglutinin (HA) and neuraminidase (NA), located on the surface of the virus. Breaking down the proteins further, there are 18 hemagglutinin subtypes and 11 different neuraminidase subtypes1. Influenza A can be even further classified into specific clades (also known as groups) and sub-clades (also known as sub-groups) based on similarity of their HA/NA gene sequences1. The Nucleocapsid protein or nucleoprotein (NP) of the influenza virus A negative-strand RNA’s primary function is to encapsulate the virus genome for the purpose of RNA transcription, replication and packaging2. Specifically, NP is the most abundant viral protein in infected cells2, therefore the NP can be and has been used for anti-influenza drug development3 The NP of influenza A and B viruses share up to 38% of their amino acid sequence, indicating region functionality differences at the amino acid level4
- Product categories: Primary Monoclonal Antibodies>Infectious Diseases|Recombinant Antibodies - Pkg Size: 500 µg - Clone: 703 - Target: Influenza A Nucleocapsid - Research Area: Infectious Disease, Seasonal and Respiratory Infections, IVD Raw Material - Antigen Distribution: The nucleocapsid protein is expressed in the internal nucleocapsid of Influenza A - Applications: ELISA - Concentration: ≥1.0 mg/ml - Formulation: This recombinant monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. - Storage and Stability: This antibody may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Suggested application(s)ELISA
Clone703
Storage temperature+4°C
Quantity500 ug
The stock indication is not contractual: this data is constantly changing and may vary depending on the quantities requested.